ULEMA FELIX: Open Payments
NPI 1134630098 · NORTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 18 payments from 9 companies in 2025. Trend: 2023 $3,202 · 2024 $886 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $91 |
| Novo Nordisk Inc | 4 | $79 |
| Lilly USA, LLC | 2 | $52 |
| PFIZER INC. | 2 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Hologic Sales and Service, LLC | 1 | $28 |
| Seqirus USA Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, Ozempic, CREON, VOWST, Wegovy, VRAYLAR, THINPREP 2000 PROCESSOR, PREVNAR 20.
Industry payments across MA — which companies pay providers there.
